160 related articles for article (PubMed ID: 31522415)
1. Strategies and Techniques for NK Cell Phenotyping.
Ziqing C; Lundqvist A; Witt K
Methods Mol Biol; 2019; 2032():105-114. PubMed ID: 31522415
[TBL] [Abstract][Full Text] [Related]
2. Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses.
Pitoiset F; Cassard L; El Soufi K; Boselli L; Grivel J; Roux A; Klatzmann D; Chaput N; Rosenzwajg M
Cytometry A; 2018 Aug; 93(8):793-802. PubMed ID: 30168890
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping Multiple Subsets of Immune Cells In Situ in FFPE Tissue Sections: An Overview of Methodologies.
Mansfield JR
Methods Mol Biol; 2017; 1546():75-99. PubMed ID: 27896758
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells as a promising therapeutic target for cancer immunotherapy.
Kim N; Lee HH; Lee HJ; Choi WS; Lee J; Kim HS
Arch Pharm Res; 2019 Jul; 42(7):591-606. PubMed ID: 30895524
[TBL] [Abstract][Full Text] [Related]
6. A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.
Kim GG; Donnenberg VS; Donnenberg AD; Gooding W; Whiteside TL
J Immunol Methods; 2007 Aug; 325(1-2):51-66. PubMed ID: 17617419
[TBL] [Abstract][Full Text] [Related]
7. High-Dimensional Flow Cytometry Analysis of Regulatory Receptors on Human T Cells, NK Cells, and NKT Cells.
Nakagawa R; Brayer J; Restrepo N; Mulé JJ; Mailloux AW
Methods Mol Biol; 2021; 2194():255-290. PubMed ID: 32926371
[TBL] [Abstract][Full Text] [Related]
8. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
9. High-Dimensional Immunophenotyping with Fluorescence-Based Cytometry: A Practical Guidebook.
Mair F; Tyznik AJ
Methods Mol Biol; 2019; 2032():1-29. PubMed ID: 31522410
[TBL] [Abstract][Full Text] [Related]
10. Flow Cytometry Analysis of NK Cell Phenotype and Function in Aging.
Tarazona R; Campos C; Pera A; Sanchez-Correa B; Solana R
Methods Mol Biol; 2015; 1343():9-18. PubMed ID: 26420705
[TBL] [Abstract][Full Text] [Related]
11. Designing multivalent proteins based on natural killer cell receptors and their ligands as immunotherapy for cancer.
Smits NC; Coupet TA; Godbersen C; Sentman CL
Expert Opin Biol Ther; 2016 Sep; 16(9):1105-12. PubMed ID: 27248342
[TBL] [Abstract][Full Text] [Related]
12. Target-induced natural killer cell loss as a measure of NK cell responses.
Warren H
Curr Protoc Immunol; 2012 Apr; Chapter 14():Unit 14.29.1-15. PubMed ID: 22470134
[TBL] [Abstract][Full Text] [Related]
13. Natural killer-dendritic cell cross-talk in cancer immunotherapy.
Kalinski P; Mailliard RB; Giermasz A; Zeh HJ; Basse P; Bartlett DL; Kirkwood JM; Lotze MT; Herberman RB
Expert Opin Biol Ther; 2005 Oct; 5(10):1303-15. PubMed ID: 16197336
[TBL] [Abstract][Full Text] [Related]
14. Targeting natural killer cells in cancer immunotherapy.
Guillerey C; Huntington ND; Smyth MJ
Nat Immunol; 2016 Aug; 17(9):1025-36. PubMed ID: 27540992
[TBL] [Abstract][Full Text] [Related]
15. Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometry.
Oetjen KA; Lindblad KE; Goswami M; Gui G; Dagur PK; Lai C; Dillon LW; McCoy JP; Hourigan CS
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518681
[TBL] [Abstract][Full Text] [Related]
16. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
[TBL] [Abstract][Full Text] [Related]
17. Phenotyping of tumor infiltrating immune cells using mass-cytometry (CyTOF).
Maby P; Corneau A; Galon J
Methods Enzymol; 2020; 632():339-368. PubMed ID: 32000904
[TBL] [Abstract][Full Text] [Related]
18. Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocyte, NK, and NKT subsets.
Mittag A; Lenz D; Gerstner AO; Sack U; Steinbrecher M; Koksch M; Raffael A; Bocsi J; Tárnok A
Cytometry A; 2005 Jun; 65(2):103-15. PubMed ID: 15830380
[TBL] [Abstract][Full Text] [Related]
19. Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective.
Cifaldi L; Locatelli F; Marasco E; Moretta L; Pistoia V
Trends Mol Med; 2017 Dec; 23(12):1156-1175. PubMed ID: 29133133
[TBL] [Abstract][Full Text] [Related]
20. NK cell-based immunotherapies in Pediatric Oncology.
McDowell KA; Hank JA; DeSantes KB; Capitini CM; Otto M; Sondel PM
J Pediatr Hematol Oncol; 2015 Mar; 37(2):79-93. PubMed ID: 25590232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
